We recommend the use of glucocorticoids in cases where conventional treatment for hirsutism is ineffective or poorly tolerated or when the post-ACTH stimulus cortisol response is less than 18 mcg/dL (Level of Evidence C). The gene discussed is POMC; the disease is Hirsutism.